Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Press Releases

Press Releases

All Releases
View Summary Spectrum Pharmaceuticals Completes $4.44 Million Financing With Institutional Investors
May 8, 2003
PDF 28.2 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Receives Nasdaq Notice
Apr 8, 2003
PDF 27.5 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Reports Fourth Quarter and Year End Financials
Mar 31, 2003
PDF 32.1 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals to Receive $1 Million Investment
Feb 7, 2003
PDF 28.0 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces Filing of First ANDA With the FDA for Approval to Market Generic Drugs in the United States
Jan 15, 2003
PDF 29.7 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Completes Equity Offering
Dec 19, 2002
PDF 27.6 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals to Expand Study of Superficial Bladder Cancer Drug
Dec 11, 2002
PDF 27.9 KB Add to Briefcase
View Summary NeoTherapeutics to Change Name to Spectrum Pharmaceuticals
Dec 9, 2002
PDF 27.6 KB Add to Briefcase
View Summary NeoTherapeutics Completes Equity Offering
Nov 22, 2002
PDF 27.8 KB Add to Briefcase
View Summary NeoTherapeutics Completes Issuance of Shares To Vendors
Nov 21, 2002
PDF 27.4 KB Add to Briefcase
View Summary NeoTherapeutics Announces Resignation of Alvin J. Glasky, Ph.D. from the Company's Board of Directors
Nov 18, 2002
PDF 27.4 KB Add to Briefcase
View Summary NASDAQ Approves NeoTherapeutics Listing on Small-Cap Market
Oct 15, 2002
PDF 27.2 KB Add to Briefcase
View Summary NeoTherapeutics Updates Implementation of Strategy
Oct 7, 2002
PDF 28.9 KB Add to Briefcase
View Summary NeoTherapeutics and GPC Biotech Sign Agreement To Co-Develop Phase 3 Oral Anti-Cancer Drug
Oct 1, 2002
PDF 30.8 KB Add to Briefcase
View Summary NeoTherapeutics Provides Update on Nasdaq Listing Status
Sep 30, 2002
PDF 27.3 KB Add to Briefcase
View Summary NeoTherapeutics Regains Compliance with NASDAQ Minimum Bid Requirement
Sep 26, 2002
PDF 27.0 KB Add to Briefcase
View Summary NeoTherapeutics' Stockholders Approve Reverse Stock Split and Proposal for New Financings
Sep 5, 2002
PDF 29.2 KB Add to Briefcase
View Summary NeoTherapeutics Announces Organizational Changes Designed to Bring On-Going Monthly Expenses Below $500,000
Aug 22, 2002
PDF 30.1 KB Add to Briefcase
View Summary NeoTherapeutics Announces New Financial Leadership
Aug 21, 2002
PDF 27.9 KB Add to Briefcase
View Summary NeoTherapeutics Announces Major Strategic Restructuring
Aug 20, 2002
PDF 27.6 KB Add to Briefcase
Showing 701-720 of 721 Page: 1 ... 32 33 34 35 36 37  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPI

Price:
19.50
Change:
- 1.23
Day High:
21.00
Day Low:
19.10
Volume:
2,141,818
4:00 PM ET on Nov 17, 2017
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools

Print Email

Search IR